Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Improvements in breast cancer detection have brought about significant changes in mortality rates among women of all ages over the past decades. And, investigators are continuing to see shifts in how the disease affects women. Later this week, look for coverage of what researchers are learning about the impact of this cancer that can strike women at any age.
For more breast cancer coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
More and more, the conversation in radiology is turning to globalization. Expanding radiology services and educational efforts worldwide is now a focus of the RSNA and many other institutions across the country. This week, Diagnostic Imaging Editorial Board member Mina Makary, M.D., interventional radiologist and assistant professor at The Ohio State University Wexner Medical Center, explores the opportunities that are available for IR in resource-limited settings. Look for his column later this week.
For additional columns by Dr. Makary, click here.
Sexual harassment and gender discrimination is still a lingering problem in medicine, as well as in radiology. Recently, a study in Academic Radiology addressed this topic, exploring how it impacts the way female radiologist perceive the industry and their future careers in it. This week, Diagnostic Imaging spoke with Prachi Agarwal, MBBS, clinical professor of radiology at Michigan Medicine, about what institutions can do to curb this culture in today’s environment. Look for our interview with her toward the end of the week.
For additional coverage on sexual harassment and gender discrimination in radiology, click here.
Deep Learning Model with DCE-MRI May Help Predict Proliferative Hepatocellular Carcinoma
May 20th 2024Incorporating dynamic contrast-enhanced MRI, a deep learning model demonstrated a 20 percent higher AUC in external validation testing than clinical factors alone and over a 17 percent higher AUC than radiological factors alone in predicting proliferative hepatocellular carcinoma (HCC).
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.